What is Nano Mobile Healthcare Inc's earnings per share (EPS)?

Nano Mobile Healthcare Inc (VNTH) reported diluted earnings per share of $-0.10 for fiscal year 2016. This represents a -266.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Nano Mobile Healthcare Inc Financials

VNTH

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2016 Currency USD FYE June

This page shows Nano Mobile Healthcare Inc (VNTH) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI VNTH FY2016 2026-04-22

Liquidity strain rather than operating scale defines this business, as obligations overwhelm a shrinking asset base.

Across the last three reported years, current resources thinned faster than liabilities: cash fell from $235K to $60K. At the same time, the current ratio slid from 0.4x to 0.04x, showing that each step down in liquidity left the company less able to meet near-term claims from liquid assets.

By the latest year, liabilities of $2.6M sat against only $104K of assets, so the business was being supported more by accumulated obligations than by resources on the balance sheet. The resulting negative equity of -$2.5M is not just an accounting label; it means past losses and claims had already consumed the recorded capital cushion.

Overhead still outran liquidity in the latest year, with SG&A at $346K versus cash of $60K. Even after SG&A had been $444K a year earlier, cost trimming alone had not closed the funding gap.

Financial Health Signals

Financial Profile 0/100

Based on FY2016 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Nano Mobile Healthcare Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Liquidity

Nano Mobile Healthcare Inc's current ratio of 0.04 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

N/A

EPS (Diluted)

$-0.10

YoY-266.7%

Nano Mobile Healthcare Inc earned $-0.10 per diluted share (EPS) in fiscal year 2016. This represents a decrease of 266.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

$60K

YoY-76.0%

5Y CAGR+33.4%

Nano Mobile Healthcare Inc held $60K in cash against $0 in long-term debt as of fiscal year 2016.

Dividends Per Share

N/A

Shares Outstanding

49M

YoY+115.8%

Nano Mobile Healthcare Inc had 49M shares outstanding in fiscal year 2016. This represents an increase of 115.8% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

N/A

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

VNTH Income Statement

Metric	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	N/A	N/A	N/A	$34	$0	$0
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$346K-22.0%	$444K+58.8%	$280K	N/A	N/A	N/A
Operating Income	N/A	N/A	N/A	-$213K+16.7%	-$256K	N/A
Interest Expense	N/A	-$665K-111.2%	-$315K-20543.6%	$2K	N/A	N/A
Income Tax	N/A	N/A	N/A	$0	$0	$0
Net Income	N/A	N/A	N/A	-$221K-22.5%	-$180K	N/A
EPS (Diluted)	$-0.10-266.7%	$0.06	$-0.06	N/A	N/A	N/A

Metric	Q1'17	Q4'16	Q3'16	Q2'16	Q1'16	Q4'15	Q3'15	Q2'15
Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	N/A	N/A	$101K+88.7%	$53K-47.7%	$102K	N/A	$105K-34.3%	$160K
Operating Income	N/A	N/A	-$195K	N/A	-$462K	N/A	N/A	-$552K
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	-$179K+24.9%	-$238K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	$407K	N/A	N/A	N/A
EPS (Diluted)	$0.00	N/A	N/A	N/A	$0.00	N/A	N/A	N/A

VNTH Balance Sheet

Metric	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$104K-65.7%	$303K-24.0%	$398K+318.2%	$95K-70.0%	$317K+2131.0%	$14K
Current Assets	$93K-68.0%	$292K-22.9%	$378K+324.7%	$89K-71.1%	$308K+2064.8%	$14K
Cash & Equivalents	$60K-76.0%	$250K+6.3%	$235K+163.9%	$89K-70.4%	$301K+2014.1%	$14K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	$0
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.6M-31.0%	$3.8M+252.4%	$1.1M+80.7%	$591K-14.3%	$689K+83.2%	$376K
Current Liabilities	$2.6M-27.9%	$3.6M+325.8%	$846K+43.2%	$591K	N/A	N/A
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$2.5M+27.9%	-$3.5M-416.9%	-$670K-35.1%	-$496K-33.3%	-$372K-2.8%	-$362K
Retained Earnings	-$6.6M+5.8%	-$7.0M+19.0%	-$8.6M	N/A	N/A	N/A

Metric	Q1'17	Q4'16	Q3'16	Q2'16	Q1'16	Q4'15	Q3'15	Q2'15
Total Assets	$405-99.6%	$104K+52.3%	$68K-9.6%	$75K-27.4%	$104K-65.7%	$303K+229.7%	$92K-30.3%	$132K
Current Assets	N/A	$93K+59.6%	$58K-10.4%	$65K-30.0%	$93K-68.0%	$292K+262.3%	$81K-32.9%	$120K
Cash & Equivalents	N/A	$60K+20.2%	$50K+51.5%	$33K-45.1%	$60K-76.0%	$250K+257.3%	$70K-30.2%	$100K
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$6.6M+154.2%	$2.6M-78.3%	$12.0M+63.4%	$7.3M+182.0%	$2.6M-31.0%	$3.8M+117.6%	$1.7M+22.0%	$1.4M
Current Liabilities	$6.6M+154.2%	$2.6M-78.1%	$11.9M+64.4%	$7.2M+202.0%	$2.4M-33.7%	$3.6M+136.2%	$1.5M+37.0%	$1.1M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$6.6M-164.8%	-$2.5M+79.1%	-$11.9M-64.2%	-$7.3M-190.7%	-$2.5M+27.9%	-$3.5M-111.3%	-$1.6M-27.4%	-$1.3M
Retained Earnings	-$12.0M-83.2%	-$6.6M+60.8%	-$16.8M-43.8%	-$11.7M-77.6%	-$6.6M+5.8%	-$7.0M+36.8%	-$11.0M-12.0%	-$9.9M

VNTH Cash Flow Statement

Metric	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	N/A	N/A	N/A	-$225K+14.4%	-$263K	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	-$12K	N/A	$0+100.0%	-$10K+79.4%	-$50K
Financing Cash Flow	N/A	N/A	N/A	-$83K-117.3%	$482K	N/A
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'17	Q4'16	Q3'16	Q2'16	Q1'16	Q4'15	Q3'15	Q2'15
Operating Cash Flow	N/A	-$435K-70.1%	-$256K	N/A	-$508K-91.0%	-$266K	N/A	-$445K
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Investing Cash Flow	N/A	N/A	N/A	N/A	N/A	$0	$0	$0
Financing Cash Flow	N/A	$385K+41.1%	$273K-25.8%	$367K+15.3%	$318K-28.6%	$446K	N/A	$445K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

VNTH Financial Ratios

Metric	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	-627661.8%	N/A	N/A
Net Margin	N/A	N/A	N/A	-648894.1%	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	-231.6%-174.9pp	-56.7%	N/A
Current Ratio	0.04-0.0	0.08-0.4	0.45+0.3	0.15	N/A	N/A
Debt-to-Equity	-1.04+0.0	-1.09+0.5	-1.59-0.4	-1.19+0.7	-1.85-0.8	-1.04
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'17	Q4'16	Q3'16	Q2'16	Q1'16	Q4'15	Q3'15	Q2'15
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	N/A	N/A	N/A	N/A	392.2%	N/A	N/A	N/A
Current Ratio	N/A	0.04+0.0	0.000.0	0.01-0.0	0.04-0.0	0.08+0.0	0.05-0.1	0.11
Debt-to-Equity	-1.00+0.0	-1.04-0.0	-1.010.0	-1.01+0.0	-1.04+0.0	-1.09-0.0	-1.06+0.0	-1.10
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Note: Shareholder equity is negative (-$2.5M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.04), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Newtopia NEWUF

$87K

Medixall MDXL

$1.2M

Cardiocomm Solut EKGGF

$909K

Achiko ACHKF

$523K

Frequently Asked Questions

What are Nano Mobile Healthcare Inc's total assets?

Nano Mobile Healthcare Inc (VNTH) had $104K in total assets as of fiscal year 2016, including both current and long-term assets.

How many shares does Nano Mobile Healthcare Inc have outstanding?

Nano Mobile Healthcare Inc (VNTH) had 49M shares outstanding as of fiscal year 2016.

What is Nano Mobile Healthcare Inc's current ratio?

Nano Mobile Healthcare Inc (VNTH) had a current ratio of 0.04 as of fiscal year 2016, which is below 1.0, which may suggest potential liquidity concerns.

What is Nano Mobile Healthcare Inc's debt-to-equity ratio?

Nano Mobile Healthcare Inc (VNTH) had a debt-to-equity ratio of -1.04 as of fiscal year 2016, measuring the company's financial leverage by comparing total debt to shareholder equity.

Why is Nano Mobile Healthcare Inc's debt-to-equity ratio negative or unusual?

Nano Mobile Healthcare Inc (VNTH) has negative shareholder equity of -$2.5M as of fiscal year 2016, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

How financially healthy is Nano Mobile Healthcare Inc?

Nano Mobile Healthcare Inc (VNTH) scores 0 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.